GLP-1 weight loss treatment at Anu Face Mind Body in Elizabethtown KY

Medical Weight Loss in Elizabethtown, KY

FDA-Approved Therapy

First Signs:1-2 weeks
Full Effect:16-20 weeks
Treatment Time:5 min weekly
Average Weight Loss:12-15%

Reset Your Hunger Signals with GLP-1 Weight Loss in Elizabethtown, KY

That number on the scale refuses to budge despite your best efforts. GLP-1 Weight Loss Treatments at Anu Face | Mind | Body in Elizabethtown, KY help reset your body’s hunger signals, making sustainable weight loss achievable without constant willpower battles.

Meet the Founder Meet the Founder

At ANU Face, Mind & Body in Elizabethtown, KY, board-certified nurse practitioner Amy Nunn APRN, AGPCNP-BC, PMHNP-BC, combines 20 years of clinical experience with telemedicine technology to deliver expert GLP-1 weight loss therapy to patients throughout Hardin County and surrounding communities.

When Willpower Isn't Enough

Before and after weight loss transformation

A Medical Solution

You've tried the diets. Counted calories. Hit the gym. Yet your body seems to fight every pound you lose. The hunger never stops, cravings derail your progress, and the scale barely moves despite genuine effort. It's not a lack of willpower—it's biology working against you. Your appetite regulation system has adapted to protect weight your body no longer needs.

GLP-1 medications work with your biology instead of against it. These FDA-approved treatments reset the hunger signals your brain sends, reducing appetite and cravings at their source. You feel satisfied with smaller portions naturally. Food noise quiets. The constant mental battle with eating subsides. Combined with lifestyle modifications, GLP-1 therapy delivers sustainable results that willpower alone cannot achieve.

GLP-1 injection pen and medication

What Is GLP-1 Weight Loss?

Receptor Agonist Therapy

GLP-1 receptor agonists are prescription medications that mimic a hormone naturally produced in your intestines. These injections slow gastric emptying and signal satiety to your brain, reducing appetite and food cravings. FDA-approved options include semaglutide and tirzepatide for chronic weight management in adults with obesity or overweight conditions with comorbidities.

These medications bind to GLP-1 receptors in your brain, particularly in areas controlling hunger and satiety. The result is reduced appetite, decreased food cravings, and earlier feelings of fullness during meals. This neuroplasticity allows your brain to relearn appropriate portion sizes.

Your provider administers a small subcutaneous injection, typically in your abdomen, thigh, or upper arm. The injection takes less than a minute to complete. Most patients start with a low dose that gradually increases over several weeks to minimize side effects.

We use the InBody Body Composition Analyzer to track changes in body fat, muscle mass, and visceral fat. This provides a far more accurate measure of success than scale weight alone, ensuring your GLP-1 and HRT programs are optimized for real results.

Treatment Timeline

First Signs
1-2 weeks (appetite reduction)
Full Effect
16-20 weeks (plateau weight)
Treatment Time
5 minutes (weekly injection)
Recovery
No downtime required
Abstract metabolic health and wellness background

GLP-1 Treatment Areas

Comprehensive Weight Management

01

Stubborn Weight

Resistant fat deposits that don't respond to diet and exercise alone - ongoing treatment with monthly monitoring

02

Appetite Control

Constant hunger, cravings, difficulty feeling satisfied - medication helps regulate hunger signals

03

Metabolic Health

Pre-diabetes, insulin resistance, blood sugar imbalances - typically 3 to 6 months for improvement

04

Emotional Eating

Food-focused thoughts, stress eating, unhealthy patterns - reduced food noise within weeks

05

Weight Regain

History of yo-yo dieting, lost weight returning - sustainable approach with long-term support

Benefits of GLP-1 Therapy

FDA-Approved Results

Patient consultation discussing GLP-1 benefits
  • 01

    Significant Weight Loss

    Patients may lose an average of 12–15% of their body weight when combined with medical supervision and lifestyle support.

  • 02

    Reduced Appetite

    GLP-1 medications naturally decrease hunger and cravings, making healthy eating feel effortless

  • 03

    Metabolic Improvements

    Beyond weight loss, see improvements in blood sugar, cholesterol, and blood pressure levels

  • 04

    Weekly Dosing

    Simple once-weekly injection fits easily into your routine without daily pills or complicated schedules

  • 05

    Sustainable Results

    Gradual weight loss combined with lifestyle coaching helps build habits for long-term success

GLP-1 Options Comparison

Finding Your Best Fit

Treatment Mechanism Administration Results Appear Average Weight Loss Best For
Semaglutide (Ozempic/Wegovy) GLP-1 receptor agonist Weekly injection 1-2 weeks 14.9% at 68 weeks Comprehensive appetite control
Tirzepatide (Mounjaro/Zepbound) Dual GLP-1/GIP agonist Weekly injection 1-2 weeks 15-22% at 72 weeks Enhanced metabolic effects
Traditional Suppressants Stimulant-based Daily oral 3-7 days 3-9% at 12 months Short-term appetite control
Confident patient considering GLP-1 therapy

Who Is a Good Candidate for GLP-1?

Eligibility Criteria

Adults with a BMI of 30 or higher, or BMI of 27 with weight-related health conditions, typically qualify for GLP-1 therapy. The best candidates understand that this represents a medical treatment requiring long-term commitment rather than a quick fix.

Ideal Candidates:

  • Adults with BMI 30+ or BMI 27+ with comorbidities
  • Patients who have tried lifestyle modifications unsuccessfully
  • Individuals committed to long-term medical therapy
  • Those with realistic weight loss expectations
  • Patients able to adhere to weekly injection schedules

We often recommend waiting if you have active eating disorders, are planning pregnancy, or expect rapid results without lifestyle changes.

Contraindications

Personal or family history of medullary thyroid carcinoma
Multiple Endocrine Neoplasia syndrome type 2
Pregnancy or planning pregnancy
Severe renal impairment
Active eating disorders

GLP-1 Treatment Overview

Initial Consultation

Your weight loss journey begins with a comprehensive evaluation including medical history review, current medications, BMI assessment, and metabolic health screening. We discuss your weight loss goals, previous attempts, and lifestyle factors to determine if GLP-1 therapy is appropriate for you.

Personalized Protocol Design

Based on your consultation, we create a customized GLP-1 treatment plan selecting the optimal medication (semaglutide or tirzepatide), starting dose, and titration schedule. We also develop complementary nutrition and activity guidelines tailored to your lifestyle and preferences.

Treatment Initiation

You receive your first GLP-1 injection with detailed instruction on self-administration technique. We review injection site rotation, proper storage, and what to expect as your body adjusts. Most patients start at a lower dose that gradually increases over several weeks.

Dose Optimization & Monitoring

Through regular check-ins (weekly to monthly), we monitor your progress, manage any side effects, and adjust dosing as needed. To go beyond the number on the scale, we utilize the InBody Body Composition Analyzer. This advanced tool measures key biomarkers like body fat percentage, muscle mass, visceral fat levels, and water distribution, giving us a precise picture of your progress. We track these trends, along with metabolic markers and overall well-being, to optimize your results while minimizing discomfort.

Long-Term Success Planning

As you approach your goals, we develop a maintenance strategy that may include continued lower-dose therapy, lifestyle modifications, or transition planning. Our focus is on sustainable results and preventing weight regain through ongoing support and periodic reassessment.

GLP-1 safety protocols and monitoring

Risks and Side Effects

What to Know

Common side effects include nausea, vomiting, and diarrhea, which occur in 15-20% of patients during initial treatment phases. These effects typically resolve within 2-4 weeks as your body adjusts to the medication.

Serious but rare risks include pancreatitis, with incidence rates of 0.1-0.2% in clinical trials. GLP-1 medications have been FDA-approved since 2017 with an excellent safety profile when prescribed by qualified healthcare providers.

Our team's medical expertise helps identify potential contraindications and minimize adverse effects through careful dosing and monitoring.

GLP-1 Therapy Cost in Elizabethtown

Pricing and Savings Options

Medical weight loss programs using GLP-1 therapy are customized based on the medication recommended, dosage requirements, and your individual health goals. During your consultation, your provider will review your medical history, discuss the available treatment options, and create a personalized plan designed to support safe and sustainable weight loss. To learn more about GLP-1 weight loss therapy and determine the best approach for your needs, schedule an appointment with our team. Flexible payment options are available to help make treatment more accessible.

Anu Face Mind Body clinic interior Elizabethtown

Why Choose ANU for Medical Weight Loss in Elizabethtown, KY

20 Years of Clinical Excellence

Medical Oversight

Nurse practitioner supervision ensures safe dosing, proper titration, and monitoring for optimal results

Holistic Support

We address the mental and emotional aspects of weight loss, not just the physical—understanding the mind-body connection

Personalized Dosing

Careful titration based on your response and tolerance minimizes side effects while maximizing results

Integrated Wellness

Combine GLP-1 therapy with peptides, IV therapy, and hormone optimization for comprehensive body transformation

Frequently Asked Questions

About GLP-1 Weight Loss

01 How long do I need to stay on GLP-1 therapy?

GLP-1 treatment is typically long-term, as discontinuing the medication leads to weight regain in most patients. We recommend viewing this as ongoing medical therapy similar to blood pressure or diabetes medications.

02 Can I combine GLP-1 with other weight loss treatments?

Yes, GLP-1 therapy often works well combined with nutritional counseling, exercise programs, and behavioral therapy. We'll coordinate with other providers to ensure safe, effective treatment combinations.

03 Will my insurance cover GLP-1 for weight loss?

Coverage varies by insurance plan and specific medication. We help patients navigate insurance requirements and can provide prior authorization support when needed.

04 What happens if I miss a weekly injection?

Take your injection as soon as you remember if it's within 5 days of your scheduled dose. If more than 5 days have passed, skip that dose and resume your regular weekly schedule.

05 Can I drink alcohol while on GLP-1 therapy?

Moderate alcohol consumption is generally acceptable, but alcohol may increase nausea risk and can interfere with weight loss goals. Discuss your alcohol consumption with your provider.

06 How quickly will I see results with GLP-1 treatment?

Most patients notice appetite reduction within the first week, with visible weight loss starting at 2-4 weeks. Peak effects typically occur between 16-20 weeks of consistent treatment.

Related Treatments

Complement your GLP-1 therapy with our other services.

Body

Comprehensive metabolic and wellness therapies designed to support sustainable weight management and long-term vitality.

Mind

Supportive mental health services that promote behavioral change, emotional balance, and long-term lifestyle success.

Location230 Buford Lane, Suite 108
Elizabethtown, KY, 42701

Schedule Your Medical Weight Loss Consultation

References

  1. 1. PubMed (PMID: 35015037) - Weekly semaglutide demonstrated superior weight reduction compared to daily liraglutide.
  2. 2. PubMed (PMID: 33567185) - Semaglutide 2.4mg weekly achieved mean weight loss of 14.9% from baseline.
  3. 3. PubMed (PMID: 33755728) - Participants who discontinued semaglutide regained two-thirds of their lost weight over 48 weeks.
  4. 4. PubMed (PMID: 36578889) - Semaglutide showed pooled mean weight loss of 12.3kg compared to placebo.
  5. 5. PubMed (PMID: 32442310) - GLP-1 receptor agonists may increase the risk of acute pancreatitis (0.1-0.2% incidence).
  6. 6. PubMed (PMID: 36566341) - GLP-1 receptor agonists contraindicated in patients with medullary thyroid carcinoma history.